Executive Responsibility in Pharma Manufacturing
This module provides executive management in pharmaceutical manufacturing with a comprehensive understanding of their legal and regulatory responsibilities under the U.S. Food, Drug, and Cosmetic Act (FD&C Act). It explores the role of the FDA in ensuring compliance, the different types of inspections conducted, and the serious consequences of non-compliance— including FDA 483s, Warning Letters, and potential legal action. The module also emphasizes the central role of a properly functioning Quality System in maintaining compliance and preventing regulatory violations.
Whether for onboarding or annual refresher training, this Module is seamlessly deployable on any LMS and can be tailored to your company’s exact needs.
Duration: 30 Mins
Grade: Core Library
Description
Learning Objectives:
Learner Benefits:
|
Module Features:
Animations |
---|
Keywords
- cGMP Regulations
- Consent Decrees
- Corporate Accountability
- Documentation and Compliance
- Executive Responsibility
- FDA Compliance
- FDA Inspections
- FDA 483s and Warning Letters
- Pharmaceutical Manufacturing
- Quality Assurance and Control
- Quality System Management
- Regulatory Risk Management